ESC 365 - Ambulatory milrinone use in an advanced heart failure unit: a useful option.

HFA Premium Access

Ambulatory milrinone use in an advanced heart failure unit: a useful option.

Session: Heart Failure ePosters - focus on Chronic Heart Failure 3

Topic: Pharmacotherapy

Speaker: Mr J. Vieitez Florez (Majadahonda, Madrid, ES)

Event: Heart Failure 2022

Congress Session

About the speaker

Mr Jose Maria Vieitez Florez

Puerta de Hierro Majadahonda University Hospital, Majadahonda, Madrid (Spain)

0 follower

35 more presentations in this session

Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial

Speaker: Professor K. Branch (Seattle, US)

Prognostic value of pulse pressure in heart failure with preserved ejection fraction: findings from the RICA registry

Speaker: Doctor I. Bravo Candela (Sevilla, ES)

Repetitive ambulatory doses of levosimendan for patients as bridge to heart transplant. Findings from the LEVO-T registry.

Speaker: Doctor J. De Juan Baguda (Madrid, ES)

Sacubitril/valsartan use patterns among older adults with heart failure in routine care: a US population-based cohort study of >25,000 medicare beneficiaries

Speaker: Doctor A. Bhatt (Boston, US)

Efficacy of sodium glucose cotransporter-2 inhibitors for heart failure with preserved and with mildly reduced ejection fraction: a systematic review and meta-analysis

Speaker: Doctor R. Cordovez (Cebu City, PH)

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 3

Speakers: Mr J. Vieitez Florez, Professor K. Branch, Doctor I. Bravo Candela, Doctor J. De Juan Baguda, Doctor A. Bhatt...

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

Related content

Open Access

GUIDE-HF - Panel discussion.

27 August 2021

ESC Premium Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: what do the guidelines say?

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

This platform is supported by